US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 119.930
  • +1.160+0.98%
Close Oct 1 16:00 ET
  • 118.492
  • -1.438-1.20%
Pre 09:09 ET
28.52BMarket Cap-51121P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q2 2024 Earnings Date

Currency：EURAug 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
135.69M
128.70M
-6.99M
Miss Est.
-19.09%
-23.26%
-5.15%
EPS
-2.01
-3.36
-1.35
Miss Est.
-154.45%
-325.32%
-67.17%
Analyst Rating
Buy

Sep 30, 2024

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.661B--
--2024/Q3-- / 618.488M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
Mar 20, 20242023/Q41.479B / 1.850B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.661B--
--2024/Q3-- / 618.488M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
Mar 20, 20242023/Q41.479B / 1.850B--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5 06:37 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    May 17 16:18 ET

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    May 6 07:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      46.67%

    • Hold

      53.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday0.00%